Financial

Barclays downgrades Stryker outlook to “underweight” — 5 key notes

By Laura Dyrda

Barclays downgraded Stryker shares, according to a Woodbridge Daily report.

Here are five things to know about the downgrade:

1. Stryker’s shares currently have an “underweight” rating, down from “equal weight.”

2. Price target for the shares went from $88 to $92 per share.

3. Stryker stock price is expected to reach $99.79 in the short term.

4. There are 14 analysts agreeing with the consensus, with a higher short term estimate at $105 and lower at $88.

5. The market cap is $34.7 billion with 378.9 million shares outstanding.

Stryker shares did drop 1.56 percent over the past week but the big picture remains bullish, according to the report, and shares posted positive gains of 1.17 percent over the last four weeks.

READ MORE HERE

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button